Spots Global Cancer Trial Database for primary liver cancer
Every month we try and update this database with for primary liver cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| PeproStat Haemostat Study in Subjects Undergoing Liver Surgery | NCT02204930 | Hemorrhage | PeproStat | 18 Years - | Haemostatix Ltd | |
| Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms | NCT01640522 | Hepatocellular ... Primary Liver C... Bile Duct Cance... Pancreatic Canc... Gallbladder Can... Colorectal Carc... Liver Metastase... | Collaborative C... Enhanced usual ... | 18 Years - | University of Pittsburgh | |
| Safety and Efficacy of Arsenic Trioxide Contained in TACE in the Treatment of HCC | NCT02018757 | Carcinoma, Hepa... | TACE containing... TACE containing... | 18 Years - 75 Years | First Hospital of China Medical University | |
| Clinical Characteristics of Primary Liver Cancer | NCT06325267 | Primary Liver C... | 18 Years - | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | ||
| Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms | NCT01640522 | Hepatocellular ... Primary Liver C... Bile Duct Cance... Pancreatic Canc... Gallbladder Can... Colorectal Carc... Liver Metastase... | Collaborative C... Enhanced usual ... | 18 Years - | University of Pittsburgh | |
| A Study of Recombinant Vaccinia Virus Prior to Sorafenib to Treat Unresectable Primary Hepatocellular Carcinoma | NCT01171651 | Carcinoma, Hepa... | JX-594 followed... | 18 Years - | SillaJen, Inc. | |
| Role PET Imaging in Response Assessment for Hepatocellular Carcinoma (HCC) | NCT01116804 | Primary Liver C... | MRI of the live... MRI after treat... PET-scan before... PET scan after ... | 18 Years - | University Hospital, Ghent | |
| Polyvinyl Alcohol Embolization Microspheres | NCT05770635 | Primary Liver C... | Embosphere and ... Polyvinyl alcoh... | 18 Years - 85 Years | Shanghai Huihe Medical Technology Co., Ltd | |
| Chinese Liver Cancer Clinical Survey | NCT03161925 | Primary Liver C... | - | Beijing Insight Science & Technology Co. Ltd. | ||
| A Multicenter RCT Study of 3DV Technology in the Diagnosis and Treatment of PLC | NCT05118451 | Primary Liver C... | 3 d visualizati... | 18 Years - 66 Years | Zhujiang Hospital | |
| PeproStat Haemostat Study in Subjects Undergoing Liver Surgery | NCT02204930 | Hemorrhage | PeproStat | 18 Years - | Haemostatix Ltd | |
| Study of Sorafenib and Transarterial Chemoembolization (TACE) to Treat Hepatocellular Carcinoma | NCT00844883 | Hepatocellular ... Hepatoma | sorafenib LC Bead-TACE | 18 Years - | Yale University | |
| Efficacy and Significance of Antiviral Therapy for Unresectable Hepatitis B Virus-related Primary Liver Cancer | NCT00824707 | Primary Liver C... | Entecavir conventional th... | 18 Years - 70 Years | Eastern Hepatobiliary Surgery Hospital | |
| A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection | NCT01829971 | Primary Liver C... SCLC Lymphoma Melanoma Multiple Myelom... Renal Cell Carc... NSCLC | MRX34 | 18 Years - | Mirna Therapeutics, Inc. | |
| Polyvinyl Alcohol Embolization Microspheres | NCT05770635 | Primary Liver C... | Embosphere and ... Polyvinyl alcoh... | 18 Years - 85 Years | Shanghai Huihe Medical Technology Co., Ltd | |
| Clinical Characteristics of Primary Liver Cancer | NCT06325267 | Primary Liver C... | 18 Years - | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | ||
| Efficacy of Intravenous Lidocaine on Postoperative Pain and Recovery in Patients Undergoing Hepatectomy | NCT04295330 | Primary Liver C... | Lidocaine Hydro... 0.9% normal sal... | 18 Years - 80 Years | West China Hospital | |
| Safety and Efficacy of Arsenic Trioxide Contained in TACE in the Treatment of HCC | NCT02018757 | Carcinoma, Hepa... | TACE containing... TACE containing... | 18 Years - 75 Years | First Hospital of China Medical University | |
| The Effect of Branched-chain Amino Acid (BCAA) on the Progression of Primary Liver Cancer | NCT02327819 | Primary Liver C... | Branched-chain ... non-BCAA protei... | 18 Years - 65 Years | Tel-Aviv Sourasky Medical Center | |
| Role PET Imaging in Response Assessment for Hepatocellular Carcinoma (HCC) | NCT01116804 | Primary Liver C... | MRI of the live... MRI after treat... PET-scan before... PET scan after ... | 18 Years - | University Hospital, Ghent | |
| Antineoplaston Therapy in Treating Patients With Primary Liver Cancer | NCT00003530 | Primary Liver C... | Antineoplaston ... | 14 Years - 99 Years | Burzynski Research Institute | |
| Preoperative Physical Activity Intervention in Patients Before Planned Liver Resection for Cancer (APACHE) | NCT03518632 | Primary Liver C... Secondary Liver... Liver Metastase... | Interval traini... Standard Oncolo... | 18 Years - | Centre Hospitalier Universitaire de Besancon | |
| RFA or Surgical Resection Combined With Neo-MASCT for Primary HCC: a Phase II Trial | NCT03067493 | Primary Liver C... Radiofrequency ... Immunotherapy Hepatectomy | Neo-MASCT | 18 Years - | Sun Yat-sen University | |
| Chinese Liver Cancer Clinical Survey | NCT03161925 | Primary Liver C... | - | Beijing Insight Science & Technology Co. Ltd. | ||
| Prospective Randomised Study of Doxorubicin in the Treatment of Hepatocellular Carcinoma by Drug-Eluting Bead Embolisation | NCT00261378 | Primary Liver C... | Transarterialch... DC Bead with Do... | 18 Years - | Boston Scientific Corporation | |
| Registry on Percutaneous Electrochemotherapy | NCT05267080 | Primary Liver C... Secondary Liver... | CLINIPORATOR | 18 Years - | Cardiovascular and Interventional Radiological Society of Europe | |
| Registry on Percutaneous Electrochemotherapy | NCT05267080 | Primary Liver C... Secondary Liver... | CLINIPORATOR | 18 Years - | Cardiovascular and Interventional Radiological Society of Europe | |
| Effect of Food and Formulation on the Pharmacokinetics, Safety, and Tolerability of GNS561 After One Single Dose (50 and 200mg) in Healthy Volunteers | NCT05353894 | Primary Liver C... | GNS561 oral tab... | 18 Years - 45 Years | Genoscience Pharma | |
| Transarterial Chemoembolization (TACE) vs. CyberKnife for Recurrent Hepatocellular Carcinoma (HCC) | NCT01318200 | Recurrent Hepat... | Transarterial C... CyberKnife SBRT | 18 Years - | Accuray Incorporated | |
| Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated Primary Liver Cancer | NCT05292443 | Primary Liver C... Hepatocellular ... Intrahepatic Ch... Combined Hepato... | Observation | 18 Years - 80 Years | Geneplus-Beijing Co. Ltd. | |
| Irreversible Electroporation of Unresectable Liver Tumors | NCT04404647 | Liver Metastase... Hepatocellular ... Bile Duct Cance... | Irreversible el... | 18 Years - | Aalborg University Hospital | |
| The Effect of Branched-chain Amino Acid (BCAA) on the Progression of Primary Liver Cancer | NCT02327819 | Primary Liver C... | Branched-chain ... non-BCAA protei... | 18 Years - 65 Years | Tel-Aviv Sourasky Medical Center | |
| Role PET Imaging in Response Assessment for Hepatocellular Carcinoma (HCC) | NCT01116804 | Primary Liver C... | MRI of the live... MRI after treat... PET-scan before... PET scan after ... | 18 Years - | University Hospital, Ghent | |
| MRI-guided Holmium-166 Radioembolization | NCT05609448 | Primary Liver C... Non-Resectable ... | MRI-guided radi... | 18 Years - | Radboud University Medical Center | |
| Effect of SAMe Treatment on Recurrence After Radical Treatment of Primary Hepatic Carcinoma | NCT03178929 | Primary Liver C... | S-Adenosyl Meth... | 18 Years - | Beijing Insight Science & Technology Co. Ltd. | |
| Effect of SAMe Treatment on Recurrence After Radical Treatment of Primary Hepatic Carcinoma | NCT03178929 | Primary Liver C... | S-Adenosyl Meth... | 18 Years - | Beijing Insight Science & Technology Co. Ltd. | |
| Recurrent Liver Cancer: Reconceptualization and Reevaluation | NCT06430983 | Recurrent Liver... Primary Liver C... | 18 Years - 75 Years | Nanjing Medical University | ||
| A Study of Recombinant Vaccinia Virus to Evaluate the Safety and Efficacy of a Transdermal Injection Within the Tumor of Patients With Primary or Metastatic Hepatic Carcinoma | NCT00629759 | Neoplasms, Live... | JX-594: Recombi... | 18 Years - | Jennerex Biotherapeutics | |
| Prospective Randomised Study of Doxorubicin in the Treatment of Hepatocellular Carcinoma by Drug-Eluting Bead Embolisation | NCT00261378 | Primary Liver C... | Transarterialch... DC Bead with Do... | 18 Years - | Boston Scientific Corporation | |
| Clinical Validation of a Fractional Administration Device for Holmium-166 SIRT | NCT05183776 | Liver Cancer Liver Metastasi... Primary Liver C... | Fractional admi... | 18 Years - | Radboud University Medical Center | |
| Effect of SAMe Treatment on Recurrence After Radical Treatment of Primary Hepatic Carcinoma | NCT03178929 | Primary Liver C... | S-Adenosyl Meth... | 18 Years - | Beijing Insight Science & Technology Co. Ltd. | |
| A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection | NCT01829971 | Primary Liver C... SCLC Lymphoma Melanoma Multiple Myelom... Renal Cell Carc... NSCLC | MRX34 | 18 Years - | Mirna Therapeutics, Inc. | |
| Liver Ablative Radiotherapy Utilising Kilovoltage Intrafraction Monitoring (KIM) | NCT02984566 | Liver Cancer | Kilovoltage Int... | 18 Years - 85 Years | University of Sydney | |
| Clinical Characteristics of Primary Liver Cancer | NCT06325267 | Primary Liver C... | 18 Years - | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | ||
| Safety of 32P BioSilicon in Patients With Hepatocellular Carcinoma | NCT00247260 | Liver Cancer | 32P BioSilicon | 18 Years - | pSiVida Limited | |
| Role PET Imaging in Response Assessment for Hepatocellular Carcinoma (HCC) | NCT01116804 | Primary Liver C... | MRI of the live... MRI after treat... PET-scan before... PET scan after ... | 18 Years - | University Hospital, Ghent | |
| Multi-center Clinical Study on the Decision Tree of Precision Hepatectomy in China Precision Hepatectomy Decision Tree | NCT05986383 | Primary Liver C... Metastatic Live... Benign Liver Ne... Hepatic Echinoc... | 18 Years - 70 Years | Beijing Tsinghua Chang Gung Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
